跳至主要内容
临床试验/JPRN-UMIN000011090
JPRN-UMIN000011090已完成未知

Reperfuse Ischemic Vessels with Endovascular Recanalization Device in JAPAN (RIVER JAPAN) - Reperfuse Ischemic Vessels with Endovascular Recanalization Device in JAPAN (RIVER JAPAN)

Johnson & Johnson K.K. Medical Company0 个研究点目标入组 50 人开始时间: 2013年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • - Acute intracranial hemorrhage - Mass effect or intracranial tumor - Extended early ischemic changes evidenced by CT or MRI - Administration of heparin within 48 hours preceding the onset of stroke and have an elevated APTT or PTT above twice of the normal range for the laboratory at presentation - Known bleeding diathesis of current use of oral anticoagulants (e.g., warfarin sodium) with International Normalized Ration (INR) > 3 - Platelet count < 30,000/mm3 - Glucose < 50 mg/dL - Severe sustained hypertension (SBP > 185mmHG or DBP > 110mmHG) refractory to pharmacological management - Life expectancy of less than 90 days - Pregnancy or females who are lactating - Current participation in an investigational drug or device study

研究者

发起方
Johnson &amp; Johnson K.K. Medical Company

相似试验